A detailed history of Arizona State Retirement System transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 39,123 shares of AUPH stock, worth $317,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,123
Previous 38,462 1.72%
Holding current value
$317,678
Previous $219,000 30.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.32 - $7.33 $3,516 - $4,845
661 Added 1.72%
39,123 $286,000
Q2 2024

Aug 05, 2024

BUY
$4.81 - $5.78 $4,656 - $5,595
968 Added 2.58%
38,462 $219,000
Q1 2024

May 07, 2024

SELL
$4.93 - $9.31 $2,928 - $5,530
-594 Reduced 1.56%
37,494 $187,000
Q4 2023

Jan 24, 2024

SELL
$7.13 - $9.49 $4,292 - $5,712
-602 Reduced 1.56%
38,088 $342,000
Q3 2023

Nov 06, 2023

BUY
$7.77 - $12.27 $20,574 - $32,490
2,648 Added 7.35%
38,690 $300,000
Q2 2023

Aug 01, 2023

BUY
$8.96 - $11.69 $9,336 - $12,180
1,042 Added 2.98%
36,042 $348,000
Q1 2023

Apr 27, 2023

BUY
$5.94 - $11.27 $5,749 - $10,909
968 Added 2.84%
35,000 $383,000
Q4 2022

Feb 07, 2023

BUY
$4.11 - $8.14 $5,310 - $10,516
1,292 Added 3.95%
34,032 $147,000
Q3 2022

Nov 07, 2022

BUY
$6.66 - $12.39 $19,114 - $35,559
2,870 Added 9.61%
32,740 $246,000
Q2 2022

Jul 28, 2022

BUY
$8.95 - $12.8 $680 - $972
76 Added 0.26%
29,870 $300,000
Q1 2022

May 04, 2022

BUY
$10.05 - $22.48 $4,221 - $9,441
420 Added 1.43%
29,794 $369,000
Q4 2021

Feb 04, 2022

BUY
$17.78 - $33.08 $25,727 - $47,866
1,447 Added 5.18%
29,374 $672,000
Q3 2021

Nov 12, 2021

BUY
$10.93 - $23.55 $305,242 - $657,680
27,927 New
27,927 $618,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.